Now more than ever, the world needs innovation in healthcare. Systems are strained, and staff and patients are suffering as a result. The good news is that NZ's healthtech solutions can address the multifaceted challenges of the sector. With an ecosystem of over 260+ firms, plus an active research community and entrepreneurial clinicians, healthtech innovations are being delivered to market, with considerable economic benefit to the country, not to mention improved patient outcomes.

Healthtech is valued at $2.6B in 2023, and is only set to grow. TIN predicts that NZ's largest healthtech firms will surpass $3.5B in revenue by 2028. Outward-facing and globally competitive, NZ’s leading healthtech firms exported 90% of their product in 2023, with 12% of total revenue redeployed into local R&D activities.

The third edition of the New Zealand Healthtech Report will provide a comprehensive update on this crucial sector. It will touch on all the key players: with profiles of firms with $5m+ in revenue, eight case studies of exciting start-ups, a directory of over 100 firms and an ecosystem of the key players. The report will discuss activity across the regions of New Zealand, as well as exploring the most important offshore markets. It will provide an update on the investment environment and provide key data-driven insights on the wider sector.

Join us at the University of Auckland to hear how innovation and investment today will help cure patients and solve problems tomorrow.